CHERYL LINDLEY: Open Payments
NPI 1518308188 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,492 in 194 payments from 28 companies in 2025. Trend: 2023 $4,439 · 2024 $2,904 · 2025 $3,492
Food & beverage: $3,492
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 28 | $481 |
| ABBVIE INC. | 25 | $464 |
| Axsome Therapeutics, Inc. | 15 | $265 |
| Corcept Therapeutics | 10 | $256 |
| Vanda Pharmaceuticals Inc. | 13 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $189 |
| Novo Nordisk Inc | 15 | $187 |
| Otsuka America Pharmaceutical, Inc. | 13 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $158 |
| Lilly USA, LLC | 4 | $157 |
Products named: VRAYLAR, Korlym, AUSTEDO XR, REXULTI, Auvelity, CAPLYTA, Kerendia, HETLIOZ.
Industry payments across NC — which companies pay providers there.
